Aurinia Pharmaceuticals (AUPH) Gross Margin Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 526.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -5.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -165.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 21,616.00 |
| 10 | Aurinia Pharmaceuticals | 2.03 Bn | 1.65 Bn | 71.20 Mn | 535.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 535.00 |
| Dec 31, 2025 | -214.00 |
| Sep 30, 2025 | -223.00 |
| Jun 30, 2025 | 541.00 |
| Mar 31, 2025 | 168.00 |
| Dec 31, 2024 | 269.00 |
| Sep 30, 2024 | 351.00 |
| Jun 30, 2024 | -1,181.00 |
| Mar 31, 2024 | -1,419.00 |
| Dec 31, 2023 | -717.00 |
| Sep 30, 2023 | -803.00 |
| Jun 30, 2023 | 191.00 |
| Mar 31, 2023 | -4.00 |
| Dec 31, 2022 | -273.00 |
| Sep 30, 2022 | -266.00 |
| Jun 30, 2022 | -102.00 |
| Mar 31, 2022 | 407.00 |
| Dec 31, 2021 | -206.00 |
| Sep 30, 2021 | -173.00 |
| Jun 30, 2021 | -465.00 |